drugset / Trial / NCT01441986
Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects
Phase 2
Completed
20 enrolled
Profil Institute for Metabolic Research GmbH
Heinrich-Heine University, Duesseldorf · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this trial is to demonstrate that dextromethorphan (DXM) and amantadine compared to placebo exert blood glucose (BG) lowering effects following an oral glucose tolerance test (OGTT) in male subjects with T2DM.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amantadine | Unknown | 100 mg | Oral |
| Subject | Dextromethorphan | Unknown | 30 mg | Oral |